Menu

Mistakes Sunk Research Ship

Investigators say human error caused a Taiwanese research vessel to drift off course and sink last year, claiming the lives of two aboard.

Mar 30, 2015
Kerry Grens

PIXABAY, UNSPLASHTaiwan’s Maritime and Port Bureau has concluded that mistakes by crewmembers contributed to a research vessel veering off course and sinking in October 2014. Two researchers aboard died in the accident.

“The committee members had thorough discussions from both the technical and legal perspectives, and they reached the unanimous conclusion that the accident was caused by personnel errors,” Chi Wen-jong, the director of the Maritime and Port Bureau, told the Taipei Times. “They also reached a consensus on the punishment to be handed down to the individuals responsible.”

A full report on the incident and the crewmembers’ punishment is yet to be released. According to the news report, those responsible could lose their seafaring licenses.

The Ocean Researcher V had turned toward shore a day into its expedition because of rough weather, but altered course, hitting a reef and sinking. Those aboard were rescued, except for Hsu Shuh-chieh, the chief scientist, and Lin I-chun.

“The ship should be equipped with devices to let both the captain and chief officer know they have deviated from the route, which they should have the ability to adjust,” Chi said. “The fact of the matter is none of them did anything to address the problem.”

Science Insider reported that the Taiwan Ocean Research Institute plans to build a replacement vessel.

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.